Murphy Usa Inc SEC Filings

Murphy USA Inc. insider plans to sell common stock under Rule 144. A holder has filed to potentially sell 4,051 shares of Murphy USA common stock through Fidelity Brokerage Services on the NYSE. The planned sale has an aggregate market value of $1,721,675.00 based on the filing. These shares were acquired from the issuer on 01/06/2026 via a stock option exercise paid in cash, and the approximate sale date listed is 01/07/2026. Murphy USA had 18,734,447 shares of this class outstanding, providing context for the size of the potential transaction.

Murphy USA Inc. director reported a new equity award in the form of restricted stock units. On 12/31/2025, the director acquired 76.734 fully vested RSUs of Murphy USA common stock at a price of $0 under the company’s 2023 Omnibus Incentive Plan. These RSUs were issued in lieu of the director’s quarterly cash retainer.

After this grant, the director beneficially owned 946.875 derivative securities, which include RSUs and related dividend equivalent units. Settlement of the RSUs and accrued dividend equivalents has been deferred until the director’s termination of service from the Board, consistent with the director’s deferral election.

Murphy USA Inc. director equity grant and deferral reported. A company director reported receiving 64.457 fully vested restricted stock units (RSUs) of Murphy USA common stock on 12/31/2025 under the 2023 Omnibus Incentive Plan. These RSUs, together with previously granted and dividend equivalent units, bring the director’s beneficially owned derivative securities to 791.772 units, held directly.

The RSUs were issued in lieu of the director’s quarterly cash retainer, reflecting equity-based board compensation. The director has elected to defer settlement of the RSUs and related dividend equivalent units until termination of service from the board, so shares will not be delivered until that time.

Murphy USA Inc. director reports grant of deferred stock units. A board member of Murphy USA Inc. (ticker MUSA) filed a Form 4 reporting an award of 79.804 restricted stock units of common stock on 12/31/2025 under the company’s 2023 Omnibus Incentive Plan. These units were issued fully vested in lieu of the director’s quarterly cash retainer and carry no exercise price.

The director elected to defer settlement of these RSUs, and related dividend equivalent units, until their termination of service from the board. Following this transaction, the director beneficially owns 985.87 derivative securities linked to Murphy USA common stock, held in direct ownership.

Murphy USA Inc. director reports no current share ownership. A Form 3 beneficial ownership report was filed for a director of Murphy USA Inc. (ticker MUSA) as of an event on 12/10/2025. The filing shows that the reporting person holds 0 shares of Murphy USA common stock in Table I, listed as directly owned. Table II, which would list options or other derivative securities, does not show any derivative positions. This indicates the director had no reportable direct or indirect equity or derivative ownership in Murphy USA at the time of the reported event.

A director of Murphy USA Inc. reported a gift of 768 shares of common stock on 12/15/2025 at a price of $0 per share. After this transaction, the director directly owns 256,780 Murphy USA common shares. The report also lists indirect beneficial ownership of 394,884 shares as beneficiary of trusts and 12,110 shares held by the director’s spouse.

Murphy USA is moving ahead with its previously announced leadership change, as Chief Executive Officer R. Andrew Clyde will retire from the CEO role and Board on December 31, 2025, and President and Chief Operating Officer Mindy K. West will become CEO and join the Board on January 1, 2026.

In connection with her promotion, Ms. West entered into a Severance Protection Agreement that, upon certain qualifying terminations within 24 months after a change in control, provides a lump-sum cash payment equal to two times her annual base salary plus target annual cash bonus and 24 months of continued health, dependent life and accident benefits, in exchange for 12 months of non-competition and non-solicitation obligations and perpetual confidentiality. Mr. Clyde signed a Transition and Advisory Services Agreement under which he will serve as a non-executive full-time employee through February 28, 2026 and then as a non-employee advisor through February 28, 2027, continue to receive his annual base salary rate, and be subject to 18 months of non-competition and non-solicitation covenants and perpetual confidentiality.

Murphy USA Inc. CEO and director reports phantom stock transaction on a Form 4. The filing shows a derivative position in 3,500 phantom stock units tied to Murphy USA common stock at a reference value of $391.69 per unit. After the reported activity, the reporting person beneficially owns 18,319.648 phantom stock units, held directly.

The phantom stock units are credited under Murphy USA’s excess benefit plan and each unit is the economic equivalent of one share of common stock. These units will be settled in cash when the executive retires or otherwise leaves service. The explanatory notes clarify that the reported activity reflects a transfer of value from the executive’s phantom stock account to another investment alternative within the same plan, in line with the plan’s terms.

Murphy USA Inc. filed a report announcing that on December 10, 2025, it appointed Michael G. Kulp to its Board of Directors. He will serve as a Class I director with a term expiring at the 2026 annual meeting of stockholders, adding to the company’s board-level oversight.

Mr. Kulp has also been appointed to the Audit Committee and the Executive Compensation Committee, placing him in key roles overseeing financial reporting and executive pay. As a non-employee director, he is eligible to participate in Murphy USA’s standard non-employee director compensation program, with equity awards governed by the company’s 2023 Omnibus Incentive Plan. The company has issued a news release with further details, which is included as an exhibit.